October 16, 2023
BioNTech evaluates impact of Pfizer’s wirte-offs on financial results
BioNTech is evaluating the potential impact of Pfizer’s write-offs and other charges related to COMIRNATY on its financial results.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
October 13, 2023
Sanofi: amlitelimab significantly improved signs and symptoms of moderate-to-severe atopic dermatitis
Positive results from a Phase 2b study (STREAM-AD) showed that amlitelimab significantly improved signs and symptoms of moderate-to-severe atopic dermatitis in adults whose disease cannot be adequately controlled with topical medications or for whom topical medications are not a recommended treatment approach.
October 13, 2023
CHMP recognizes urgent medical need for treating Duchenne patients
CHMP has adopted a positive opinion in favor of approval of a Swiss specialty pharmaceutical company Santhera Pharmaceuticals’ AGAMREE (vamorolone) for the treatment of Duchenne Muscular Dystrophy patients aged 4 years and older.
October 13, 2023
Genevant Sciences LNP techn used in samRNA Covid-19 vaccine candidate behind Gritstone bio’s BARDA award
Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust and expansive lipid nanoparticle (LNP) patent…
October 13, 2023
Cellectis and Imagine Institute post successful demonstration of PIK3CD gene correction
Cellectis, a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today the…
October 9, 2023
New Safety Data Suggests Esketamine Nasal Spray Spravato is more tolerable and effective compared to Quetiapine Extended-Release (XR) in adults with treatment-resistant major depressive disorder
The new safety data is from the ESCAPE-TRD Phase 3b study, which showed esketamine NS demonstrated a significant increase in…
October 6, 2023
Medexprim appoints Chief Product and Technical Officer
Medexprim has appointed Montaine Marteau as Chief Product and Technical Officer (CPTO), concurrently with her integration into the company’s Executive Committee, alongside Romain Cazavan, Nicolas Dubost and Fabrice Pillon.
October 5, 2023
NICE recommends Jardiance for use as an option for chronic heart failure
The National Institute for Health and Care Excellence (NICE) announced Thursday that empagliflozin (Jardiance) is recommended for use as an option for treating symptomatic chronic heart failure with preserved or mildly reduced ejection fraction in adults.
October 5, 2023
AstraZeneca settles Nexium and Prilosec product liability litigations
AstraZeneca said Tuesday it has made agreements in the product liability litigations related to Nexium and Prilosec. The company said…
October 4, 2023
Moderna’s combo vaccine shows strong immunogenicity against influenza and COVID-19
Moderna announced Wednesday positive results from a clinical trial of mRNA-1083, its combination mRNA combination flu/COVID vaccine.